These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 31665353)

  • 1. β-Lactam pharmacodynamics in Gram-negative bloodstream infections in the critically ill.
    Wong G; Taccone F; Villois P; Scheetz MH; Rhodes NJ; Briscoe S; McWhinney B; Nunez-Nunez M; Ungerer J; Lipman J; Roberts JA
    J Antimicrob Chemother; 2020 Feb; 75(2):429-433. PubMed ID: 31665353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
    Burgess DS; Frei CR
    J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock.
    Taccone FS; Laterre PF; Dugernier T; Spapen H; Delattre I; Wittebole X; De Backer D; Layeux B; Wallemacq P; Vincent JL; Jacobs F
    Crit Care; 2010; 14(4):R126. PubMed ID: 20594297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time Above All Else: Pharmacodynamic Analysis of β-Lactams in Critically Ill Patients.
    Landmesser KB; Clark JA; Burgess DS
    J Clin Pharmacol; 2022 Apr; 62(4):479-485. PubMed ID: 34614542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative bactericidal activity of representative β-lactams against Enterobacterales, Acinetobacter baumannii and Pseudomonas aeruginosa.
    Noel AR; Attwood M; Bowker KE; MacGowan AP; Albur M
    J Antimicrob Chemother; 2022 Apr; 77(5):1306-1312. PubMed ID: 35137096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of extended-spectrum beta-lactams on gram-negative bacterial resistance.
    Paladino JA; Sunderlin JL; Singer ME; Adelman MH; Schentag JJ
    Am J Health Syst Pharm; 2008 Jun; 65(12):1154-9. PubMed ID: 18541686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan.
    Hsueh PR; Chen WH; Luh KT
    Int J Antimicrob Agents; 2005 Dec; 26(6):463-72. PubMed ID: 16280243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
    Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
    Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic/pharmacodynamic target attainment of intravenous β-lactam regimens against Gram-negative bacteria isolated in a Brazilian teaching hospital.
    Furtado GH; Cardinal L; Macedo RS; Silva JO; Medeiros EA; Kuti JL; Nicolau DP
    Rev Soc Bras Med Trop; 2015; 48(5):539-45. PubMed ID: 26516962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Pharmacodynamic Profiling for the Selection of Optimal β-lactam Regimens in a Large University Hospital.
    Koomanachai P; Yungyuen T; Disthaporn P; Kiratisin P; Nicolau DP
    Int J Infect Dis; 2016 May; 46():22-6. PubMed ID: 27021531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefepime free minimum concentration to minimum inhibitory concentration (fCmin/MIC) ratio predicts clinical failure in patients with Gram-negative bacterial pneumonia.
    Aitken SL; Altshuler J; Guervil DJ; Hirsch EB; Ostrosky-Zeichner LL; Ericsson CD; Tam VH
    Int J Antimicrob Agents; 2015 May; 45(5):541-4. PubMed ID: 25665726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN; Sader HS; Fritsche TR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of studies on extended versus standard infusion of beta-lactam antibiotics.
    Chen M; Buurma V; Shah M; Fahim G
    Am J Health Syst Pharm; 2019 Sep; 76(18):1383-1394. PubMed ID: 31505562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
    Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
    Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-lactams in continuous infusion for Gram-negative bacilli osteoarticular infections: an easy method for clinical use.
    Ribera A; Soldevila L; Rigo-Bonnin R; Tubau F; Padullés A; Gómez-Junyent J; Ariza J; Murillo O
    Infection; 2018 Apr; 46(2):239-244. PubMed ID: 29363049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)].
    Zarakolu P; Hasçelik G; Unal S
    Mikrobiyol Bul; 2006 Jul; 40(3):147-54. PubMed ID: 17001842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of susceptibility profiles of Gram-negative bacteria before and after the introduction of ertapenem at a medical center in northern Taiwan from 2004 to 2010.
    Lee CM; Lai CC; Wang YY; Lee MC; Hsueh PR
    Diagn Microbiol Infect Dis; 2013 Jan; 75(1):94-100. PubMed ID: 23116904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-lactam target attainment and associated outcomes in patients with bloodstream infections.
    Alshaer MH; Maranchick N; Alexander KM; Manigaba K; Shoulders BR; Felton TW; Mathew SK; Peloquin CA
    Int J Antimicrob Agents; 2023 Mar; 61(3):106727. PubMed ID: 36646230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining β-lactam exposure threshold to suppress resistance development in Gram-negative bacteria.
    Tam VH; Chang KT; Zhou J; Ledesma KR; Phe K; Gao S; Van Bambeke F; Sánchez-Díaz AM; Zamorano L; Oliver A; Cantón R
    J Antimicrob Chemother; 2017 May; 72(5):1421-1428. PubMed ID: 28158470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic modeling of intravenous antibiotics against gram-negative bacteria collected in the United States.
    Koomanachai P; Bulik CC; Kuti JL; Nicolau DP
    Clin Ther; 2010 Apr; 32(4):766-79. PubMed ID: 20435246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.